Predictors of survival following relapse or progression of small cell lung cancer. Southwest oncology group study 8605 report and analysis of recurrent disease data base

Nonparametric Estimation from Incomplete Observations

1992 • 45,923 citations

Nonparametric Estimation from Incomplete Observations

1958 • 37,219 citations

Regression Models and Life-Tables

1992 • 27,454 citations

The Analysis of Binary Data.

1971 • 2,339 citations

Determinants of improved outcome in small-cell lung cancer: an analysis of the 2,580-patient Southwest Oncology Group data base.

1990 • 385 citations

Prognostic factors in small-cell carcinoma of the lung: an analysis of 1,521 patients.

1989 • 230 citations

Prognostic factors in small cell lung cancer: Multivariate model based on 778 patients treated with chemotherapy with or without irradiation

1987 • 218 citations

Prolonged administration of oral etoposide in patients with relapsed or refractory small-cell lung cancer: a phase II trial.

1990 • 217 citations

Etoposide (VP-16) and cisplatin: an effective treatment for relapse in small-cell lung cancer.

1985 • 188 citations

Therapy of small cell lung cancer: a perspective on two decades of clinical research.

1988 • 168 citations

The effect of cytosine arabinoside on the frequency of single-strand breaks in DNA of mammalian cells following irradiation or chemical treatment

1977 • 163 citations

Apurinic/apyrimidinic endonucleases in repair of pyrimidine dimers and other lesions in DNA.

1980 • 163 citations

Small-cell carcinoma of the lung: derivation of a prognostic staging system.

1991 • 143 citations

Inhibition of DNA excision repair in human cells by arabinofuranosyl cytosine: effect on normal and xeroderma pigmentosum cells.

1979 • 135 citations

The quantitation by gas chromatography-chemical ionisation-mass spectrometry of cyclophosphamide, phosphoramide mustard and nornitrogen mustard in the plasma and urine of patients receiving cyclophosphamide therapy

1978 • 135 citations

Long-term Survival and Toxicity in Small Cell Lung Cancer

1991 • 115 citations

Cross-linking and repair of DNA in sensitive and resistant strains of E. coli treated with nitrogen mustard.

1965 • 100 citations

Defective removal of DNA cross-links in a repair-deficient mutant of Chinese hamster cells.

1982 • 91 citations

1-beta-D-arabinofuranosylcytosine and hydroxyurea production of cytotoxic synergy with cis-diamminedichloroplatinum(II) and modification of platinum-induced DNA interstrand cross-linking.

1989 • 56 citations

DNA cross-linking by in vivo treatment with 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea of sensitive and resistant human colon carcinoma xenograms in nude mice.

1978 • 52 citations

Mice, men, mustards and methylated xanthines: the potential role of caffeine and related drugs in the sensitization of human tumours to alkylating agents

1981 • 48 citations

Differential repair of 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea-induced DNA damage in two human colon tumor cell lines.

1978 • 40 citations

Epirubicin in extensive small-cell lung cancer: a phase II study in previously untreated patients: a National Cancer Institute of Canada Clinical Trials Group Study.

1990 • 40 citations

Diffuse aggressive lymphomas: a curable subset of non-Hodgkin's lymphomas.

1986 • 39 citations

Lethal effects of 1-beta-D-arabinofuranosylcytosine incorporation into deoxyribonucleic acid during ultraviolet repair.

1984 • 36 citations

Phase II study of amonafide: results of treatment and lessons learned from the study of an investigational agent in previously untreated patients with extensive small-cell lung cancer.

1990 • 28 citations

Comparison of etoposide and cisplatin with bis-chloro-ethylnitrosourea, thiotepa, vincristine, and cyclophosphamide for salvage treatment in small cell lung cancer. A Southwest Oncology Group Study

1990 • 25 citations

Continuous infusion of high-dose 1-beta-D-arabinofuranosylcytosine: a phase I and pharmacological study.

1985 • 14 citations

Cytotoxic synergy of cisplatin with concurrent hydroxyurea and cytarabine: summary of an in vitro model and initial clinical pilot experience.

1992 • 9 citations

Resistance of mouse lymphoma l5178yaii cells to alkylation with methylmethane sulphonate resides in a late step of excision repair

1984 • 4 citations